This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
MarketWatch·2026-09-22 23:46

公司核心动态 - Viking Therapeutics正在开发VK2735,这是一种GLP-1/GIP药物[1] - VK2735可能直接与礼来公司的Zepbound竞争[1] - 该公司的股价因这一进展而大幅上涨[1]

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month - Reportify